Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

被引：8
|
作者：
Peixoto, Renata D'Alpino
Kumar, Aalok
Speers, Caroline
Renouf, Daniel John
Kennecke, Hagen F.
Lim, Howard John
Cheung, Winson Y.
Melosky, Barbara L.
Gill, Sharlene
机构：
[1] BC Canc Agcy, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3561
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Three versus six months adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: The French participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.
    Andre, Thierry
    Bonnetain, Franck
    Mineur, Laurent
    Bennouna, Jaafar
    Desrame, Jerome
    Faroux, Roger
    Dauba, Jerome
    Vernerey, Dewi
    Aissat, Nasredine
    Louvet, Christophe
    Lepere, Celine
    Dupuis, Olivier Jean Marie
    Becouarn, Yves
    Mabro, May
    Egreteau, Joelle
    Bouche, Olivier
    Deplanque, Gael
    Ychou, Marc
    De Gramont, Aimery
    Taieb, Julien
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II-III colon cancer: a meta-analysis
    Kuang, Ziyu
    Wang, Jiaxi
    Liu, Kexin
    Wu, Jingyuan
    Li, Jie
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (05) : 3030 - 3038
  • [33] Impact of adjuvant chemotherapy on recurrence risk in stage II colon cancer.
    Adesoye, Taiwo
    Hu, Chung-Yuan
    Cuddy, Amanda
    Francescatti, Amanda B.
    Schumacher, Jessica R.
    You, Y. Nancy
    Van Loon, Katherine
    Schrag, Deborah
    McKellar, Daniel P.
    Winchester, David Porter
    Chang, George J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
    Baek, Moo-Jun
    [J]. ANNALS OF COLOPROCTOLOGY, 2015, 31 (03) : 81 - 81
  • [35] Adjuvant Chemotherapy for Stage III Colon Cancer
    Taieb, Julien
    Gallois, Claire
    [J]. CANCERS, 2020, 12 (09) : 1 - 17
  • [36] Adjuvant chemotherapy of stage III colon cancer
    Benson, AB
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S74 - S77
  • [37] Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion
    Wise, Paul
    Efron, Jonathan
    Foley, Eugene F.
    Migaly, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 678 - +
  • [38] Estimating the optimal rate of adjuvant chemotherapy utilization in stage III colon cancer.
    Karim, Safiya
    Brennan, Kelly
    Peng, Yingwei
    Mackillop, William J.
    Booth, Christopher M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Effect of postoperative complications on adjuvant chemotherapy use in stage III colon cancer.
    Merkow, Ryan P.
    Bentrem, David J.
    Chow, Warren B.
    Cohen, Mark E.
    Ko, Clifford Y.
    Bilimoria, Karl Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [40] Comparative Effectiveness of Oxaliplatin vs Non-Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer
    Sanoff, Hanna K.
    Carpenter, William R.
    Martin, Christopher F.
    Sargent, Daniel J.
    Meyerhardt, Jeffrey A.
    Stuermer, Til
    Fine, Jason P.
    Weeks, Jane
    Niland, Joyce
    Kahn, Katherine L.
    Schymura, Maria J.
    Schrag, Deborah
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (03) : 211 - 227
12345